One of the leading world manufacturers of APIs is exploring the pharmaceutical market for an acquisition target of a mid-sized going concern in generic pharma space. The target they are looking for must have its own dossiers / MAs. The buyer is looking at Europe and the UK. As the company is successful, the acquisition can start after a suiting target occurs, funding is ready.
The buyer is a large Asian pharma company with almost 60 years of history and global presence. The company is operating globally with exports to more than 100 countries. The buyer has its own manufacturing set up in API to finished dosage formulations. Currently, the buyer is expanding in the area of Generics in UK and EU zone.
The company is well-established in the Asian continent but has diverse client portfolio with customers from Africa, Asia, Australia, Europe, and the US.
The company is focused on manufacture and sales of
The company is particularly strong in the anti-malaricals market. The company is becoming one of the largest formulation exporters from the Asian region. The company is financially very strong.
Contact us to get details about this generic pharma sales and marketing company buyer
The company is looking for a well established, mid-size company, operating in the generics marketing and sales industry. The buyer would prefer if the target had a presence in Rx as well as OTC segment. The target must have its own sales, marketing, and logistics supply chain management team. It would be preferred if the company had its own sales & marketing set up, QP and logistics in-house. Also, it would be of highly appreciated if the company had its own marketing authorizations granted.
Geographically, the company can be from any country in Europe, but preferably in larger countries such as Germany, France, Spain, Italy, the UK etc. The target should have a stable or growing revenue between 5 - 25M EUR and have a positive yearly EBITDA in the last years. The valuation will be a subject of discussion, the acquisition would be financed from its own funds.
The buyer company has already made an acquisition - outside of Europe in the recent past. The acquisition would help the target company mainly with an expansion of its presence in more geographies and vertical integration. The target would be implemented under a strong brand and financially backed up, if necessary.
Feel free to contact us for more information regarding this generic sales company wanted in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.